Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  NMCD. Nutrition Metabolism and Cardiovascular Diseases

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.numecd.2012.02.007PMID 22546554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.

  2012cited by this paper
• The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance

  2012cited by this paper
• Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency.

  2011cited by this paper
• Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.

  2011cited by this paper
• Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

  2011cited by this paper
• Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease

  2011cited by this paper
• Obesity and metabolic syndrome: potential benefit from specific nutritional components.

  2011cited by this paper
• One-hour post-load plasma glucose levels are associated with elevated liver enzymes.

  2011cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010cited by this paper
• Contribution of Gut Bacteria to Liver Pathobiology

  2010cited by this paper
• The role of the gut microbiota in nonalcoholic fatty liver disease

  2010cited by this paper
• Epithelial crosstalk at the microbiota–mucosal interface

  2010cited by this paper
• Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury.

  2010cited by this paper
• Nonalcoholic fatty liver disease.

  2010cited by this paper
• Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

  2010cited by this paper
• Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

  2010cited by this paper
• The gut‐liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?

  2009cited by this paper
• The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis

  2009cited by this paper
• REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Microbes in Gastrointestinal Health and Disease

  2009cited by this paper
• VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice

  2009cited by this paper
• The role of the gut microbiota in energy metabolism and metabolic disease.

  2009cited by this paper
• Probiotics for preventive health.

  2009cited by this paper
• Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

  2009cited by this paper
• Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

  2008cited by this paper
• Alterations in intestinal microbial flora and human disease

  2008cited by this paper
• Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

  2008cited by this paper
• Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

  2007cited by this paper
• Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis

  2007cited by this paper
• Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.

  2007cited by this paper
• Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.

  2007cited by this paper
• Role of Kupffer cells in host defense and liver disease

  2006cited by this paper
• Microbial ecology: Human gut microbes associated with obesity

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• The gut flora as a forgotten organ

  2006cited by this paper
• Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

  2005cited by this paper
• Diversity of the Human Intestinal Microbial Flora

  2005cited by this paper
• The gut microbiota as an environmental factor that regulates fat storage.

  2004cited by this paper
• A Potential Target for the Prevention and Treatment of Steatohepatitis

  2004cited by this paper
• Honor thy symbionts

  2003cited by this paper
• Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

  2003cited by this paper
• Gut flora in health and disease.

  2003cited by this paper
• Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics.

  2003cited by this paper
• Intestinal endotoxemia as a pathogenetic mechanism in liver failure.

  2002cited by this paper
• Review: The role of the liver in the response to LPS: experimental and clinical findings

  2002cited by this paper
• The host-microbe interface within the gut.

  2002cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

  2001cited by this paper
• Gut-liver axis

  2000cited by this paper
• Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.

  1991cited by this paper
• Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition.

  1982cited by this paper

• Alterations in Gut Microbiota and Their Association with Nutrition and Disease Progression in Advanced Schistosomiasis.

  2026cites this paper
• Chitosan/selenium nanoparticles Pickering emulsion prolong quercetin retention time to ameliorates cognitive disorder: Focus on restoring the metabolic disorder and gut microbiota.

  2026cites this paper
• Pathogenesis and intervention strategies for metabolic dysfunction-associated fatty liver disease from the perspective of the gut-microbiota-liver axis.

  2026cites this paper
• The synergistic regulation of fat reduction mechanism by tea polyphenols through the gut-microbial-brain axis and gut-liver axis.

  2026cites this paper
• Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities.

  2026cites this paper
• Exploring the pathogenesis of NAFLD: a study of the correlation of gut microbes and metabolites in humanized mouse gut microbiota

  2026cites this paper
• Deciphering the TLR4 and NLRP3 Inflammasome Crosstalk for Therapeutic Restoration of Intestinal and Systemic Immunity.

  2026cites this paper
• Active compounds and target genes investigation for Tongxie-Yaofang treatment in diarrhea predominant-irritable bowel syndrome based on network pharmacology study

  2025cites this paper
• Computational analysis of the gut microbiota-mediated drug metabolism

  2025cites this paper
• Gut-Liver-Immune Modular Multi-organ Chip for Non-alcoholic Fatty Liver Disease (NAFLD) Model

  2025cites this paper
• Evaluation of Defensins as Markers of Gut Microbiota Disturbances in Children with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  2025cites this paper
• Modeling the weaning diet of piglets with fermented feed material: effects on growth performance and health parameters

  2025cites this paper
• Transfer toxicity of polystyrene microplastics in vivo: Multi-organ crosstalk.

  2025cites this paper
• Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

  2025cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes

  2025cites this paper
• A new perspective on non-invasive diagnosis of non- alcoholic fatty liver disease: evidence integration of inflammatory and metabolic biomarkers based on a scoping review

  2025cites this paper
• Validating hepatoprotective potency of caffeic acid targeting BCL-2/Caspase-3 axis against endotoxin-driven liver toxicity: an in vivo and in silico approach

  2025cites this paper
• Research Advances in the Association Between Gut Microbiota and Hepatic Alveolar Echinococcosis: A Review Study

  2025cites this paper
• Exploring the significance of gut microbiota in cardiovascular health

  2025cites this paper
• Small Intestinal Bacterial Overgrowth and Pediatric Obesity—A Systematic Review

  2025cites this paper
• Ginseng-derived exosome-like nanovesicles protect against liver fibrosis by regulating TIMP2 pathways and gut dysbiosis

  2025cites this paper
• Biomedical Treatment Nanomotors Based on the Intestinal Axis: Current Challenges.

  2025cites this paper
• Regulatory effects of the bidirectional crosstalk between hepatic gene expressions and gut microbiota on the productive performances and egg quality of induced molting treated layer hens

  2025cites this paper
• Soy Isoflavones Mitigate High-Fat Diet-Induced Oxidative Stress and Inflammation in the Gut of Monopterus albus via Gut Microbiota Remodeling

  2025cites this paper
• Computational Analysis of the Gut Microbiota-Mediated Drug Metabolism

  2024cites this paper
• Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route

  2024cites this paper
• Mechanistic insight of neurodegeneration due to micro/nano-plastic-induced gut dysbiosis

  2024cites this paper
• The Beneficial Effects of Microalgae in Promoting Growth Performance of Poultry Under Heat Stress Conditions – A Review

  2024cites this paper
• Edaravone Ameliorate Inflammation in Vitamin D3 and High Fat Diet Induced Atherosclerosis in Rat via Alteration of Inflammatory Pathway and Gut Microbiota

  2024cites this paper
• Screening of Lactic Acid Bacteria Strains from Chinese Fermented Food (Suanshui) and its Protective Effect on Acute Liver Injury in Mice

  2024cites this paper
• Involvement of CircRNAs in Regulating The "New Generation of Cancer Hallmarks": A Special Depiction on Hepatocellular Carcinoma.

  2024cites this paper
• Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics

  2024cites this paper
• Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review

  2024cites this paper
• The Leaky Gut and Human Diseases: “Can’t Fill the Cup if You Don’t Plug the Holes First”

  2024cites this paper
• Dysfunction of the Murine Liver with Aging and Its Improvement with the Continuous Consumption of Enterococcus faecalis EC-12

  2024cites this paper
• Meta-analysis of randomized controlled trials of the effects of synbiotics, probiotics, or prebiotics in controlling glucose homeostasis in non-alcoholic fatty liver disease patients.

  2024cites this paper
• Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides–TLR4 Axis Downregulation

  2024cites this paper
• Impact of Some Natural and Artificial Sweeteners Consumption on Different Hormonal Levels and Inflammatory Cytokines in Male Rats: In Vivo and In Silico Studies

  2024cites this paper
• Serum Zonulin as a Marker of Intestinal Mucosal Barrier Function in Chronic Liver Diseases in Pediatrics

  2024cites this paper
• Altered metabolome and microbiome associated with compromised intestinal barrier induced hepatic lipid metabolic disorder in mice after subacute and subchronic ozone exposure.

  2024cites this paper
• Components from Curcuma longa (Turmeric) Against Hepatobiliary Diseases Based on Gut-Liver Axis: Pharmacotherapeutic Properties and Potential Clinical Applications.

  2024cites this paper
• Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease

  2024cites this paper
• Fiber and whole grain intakes in relation to liver cancer risk: An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies

  2024cites this paper
• Effects of replacing fishmeal with soybean meal on the immune and antioxidant capacity, and intestinal metabolic functions of red swamp crayfish Procambarus clarkii.

  2024cites this paper
• Palygorskite improves growth performance and prevents liver damage in avian pathogenic Escherichia coli-challenged broiler chickens at an early age.

  2024cites this paper
• A study on the effects of replacing fishmeal with soybean meal in the feed of Procambarus clarkii: Assessing growth performance, immunity, and gut microbiota

  2024cites this paper
• Pathogenesis of Alcoholic Fatty Liver a Narrative Review

  2023cites this paper
• The Significance of Dysbiosis in the Gut Microbiome to HCV Infection and Disease Progression

  2023cites this paper
• Impacts of gut microbiota alteration on age-related chronic liver diseases.

  2023cites this paper
• Evaluation of the cytotoxicity and genotoxicity potential of synthetic diacetyl food flavoring in silico, in vivo, and in vitro.

  2023cites this paper
• Diagnostic and Prognostic Value of IL-10, FABP2 and LPS Levels in HCC Patients

  2023cites this paper
• The potential toxicity of microplastics on human health.

  2023cites this paper
• Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD

  2023cites this paper
• Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions

  2023cites this paper
• Toxicity of Polystyrene Nanoplastics in the Liver and Intestine of Normal and High‐Fat‐Diet Juvenile Zebrafish

  2023cites this paper
• Roles of human gut microbiota in liver cirrhosis risk: a two-sample mendelian randomization study.

  2023cites this paper
• Mendelian randomization supports causality between gut microbiota and chronic hepatitis B

  2023cites this paper
• Dietary supplementation of microalgae mitigates the negative effects of heat stress in broilers

  2023cites this paper
• Recent Advances in Microbiota-Associated Metabolites in Heart Failure

  2023cites this paper
• Chronotoxicity of Acrylamide in Mice Fed a High-Fat Diet: The Involvement of Liver CYP2E1 Upregulation and Gut Leakage

  2023influential citation
• Hydroxypropyl-beta-Cyclodextrin embedded resveratrol regulates gut microbiota to prevent NAFLD via activating AMPK signaling pathway

  2023cites this paper
• Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis

  2023cites this paper
• Effects of Zhenggan Huayu decoction combined with entecavir on gut microbiota in patients with chronic hepatitis B fibrosis.

  2023cites this paper
• Alteration of Gut microbiota during HIV infection

  2023cites this paper
• Study on Effects of Probiotics on Gut Microbiome and Clinical Course in Patients with Critical Care Illnesses

  2023cites this paper
• Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

  2023cites this paper
• L-amino acid oxidase-1 is involved in the gut-liver axis by regulating 5-aminolevulinic acid production in mice

  2023cites this paper
• Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)

  2023cites this paper
• Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice

  2023cites this paper
• Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.

  2023cites this paper
• Study on the promotive effect and mechanism of exogenous nucleotides on Lactobacillus casei antagonism against Salmonella enterica by coculture

  2023cites this paper
• Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease

  2023cites this paper
• The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology

  2023cites this paper
• Effects of dietary Galla Chinensis tannin supplementation on immune function and liver health in broiler chickens challenged with lipopolysaccharide

  2023cites this paper
• The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Diet-Induced Microbiome’s Impact on Heart Failure: A Double-Edged Sword

  2023influential citation
• Saccharomyces cerevisiae as probiotic, prebiotic, synbiotic, postbiotics and parabiotics in aquaculture: An overview

  2023cites this paper
• Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice

  2023cites this paper
• Meta-analysis of the gut microbiota alterations in patients with gastric cancer in China

  2023cites this paper
• Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet

  2023cites this paper
• Mediterranean Diet Improves Plasma Biomarkers Related to Oxidative Stress and Inflammatory Process in Patients with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Assessment of Nonalcoholic Fatty Liver Disease Symptoms and Gut–Liver Axis Status in Zebrafish after Exposure to Polystyrene Microplastics and Oxytetracycline, Alone and in Combination

  2023cites this paper
• Exploring the potential impact of probiotic use on drug metabolism and efficacy.

  2023cites this paper
• The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective

  2023cites this paper
• Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease

  2023cites this paper
• Gallotannin Isolated from Pericarp of Water Caltrop Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.

  2023cites this paper
• Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics

  2023cites this paper
• Gut lumen-targeted oral delivery system for bioactive agents to regulate gut microbiome

  2022cites this paper
• The role of gut microflora dysbiosis in clinical manifestation of patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

  2022cites this paper
• Polysaccharide from Salviae miltiorrhizae Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut–Liver Axis

  2022cites this paper
• Features of respiratory tests (hydrogen + methane), indirect liver elastometry data in COVID-19 convalescents (pilot study)

  2022cites this paper
• The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis

  2022cites this paper
• Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and Anxiety

  2022cites this paper
• Alterations in circadian rhythms aggravate Acetaminophen-induced liver injury in mice by influencing Acetaminophen metabolization and increasing intestinal permeability

  2022cites this paper
• Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development

  2022cites this paper
• Chondroitin sulfate stimulates the secretion of H2S by Desulfovibrio to improve insulin sensitivity in NAFLD mice.

  2022cites this paper
• Dynamics in Circulating y -55Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial

  2022cites this paper
• Interaction Between Cecal Metabolites and Liver Lipid Metabolism Pathways During Induced Molting in Laying Hens

  2022cites this paper
• The Gut Microbiome and Ferroptosis in MAFLD

  2022cites this paper
• Neurotensin modulation of lipopolysaccharide induced inflammation of gut-liver axis: Evaluation using neurotensin receptor agonist and antagonist.

  2022cites this paper